VITA 34 International AG: VITA 34 plans further growth in 2011 and international expansion
VITA 34 International AG / Key word(s): Final Results 24.03.2011 09:31 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- VITA 34 International AG: VITA 34 plans further growth in 2011 and international expansion - Sales forecast of more than 18m Euro for 2011 - Marked improvement of profitability expected - Entry in the Slovakian market scheduled for 2011 - Confirmation of the preliminary figures for 2010 Leipzig, March 24, 2011 - The VITA 34 International AG (ISIN DE000A0BL849), parent company of the oldest umbilical cord blood bank for individual provision in Europe, VITA 34 AG, wants to continue its growth in the current business year 2011 and aims at increasing the revenue from approximately 17m Euro in 2010 to more than 18m Euro. It is also intended to further increase the number of storages. With 11,038 umbilical cord blood storages in the expired period under review 2010, VITA 34 has achieved the highest number of storages ever in the company's history. Furthermore, the company confirms the published preliminary figures for the business year 2010. VITA 34 also plans to considerably improve the profitability in 2011. In 2010, the company had already increased the earnings before interest and taxes (EBIT) to 0.7m Euro from 0.2m Euro in the year before. This results in an EBIT margin of 4.4 percent. In the medium term, this margin is to be increased to a minimum of 10 percent. The successful international sales, which account for about one third of the storages, contribute to the company's growth. The principal share is generated on the Spanish market, in which VITA 34 is represented by its subsidiary Secuvita, S. L. Through cooperations, VITA 34 is also actively operating in Italy, Slovenia, and in Switzerland. In order to secure future potentials for growth, VITA 34 wants to develop the international business and expand in Slovakia still in 2011. Some 60,000 babies are born each year in Slovakia. This market is attractive, among other things, because of the low degree of competition and is to additionally contribute to the operating income in the medium term already. The complete annual report is available for download on www.vita34group.com. Press / Investor Relations: Axel Mühlhaus Dr. Sönke Knop edicto GmbH Eschersheimer Landstr. 42 D-60322 Frankfurt a.M. Phone: +49 (069) 90550550 Fax: +49 (069) 90550577 E-mail: vita34@edicto.de 24.03.2011 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: VITA 34 International AG Deutscher Platz 5a 04103 Leipzig Deutschland Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: info@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------